Sidoti downgraded CBIZ from Buy to Neutral and set a new price target of $58.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/12/2024 | $80.00 → $86.00 | Neutral → Buy | Sidoti |
| 1/2/2024 | Buy → Neutral | Sidoti | |
| 10/30/2023 | $63.00 | Neutral → Buy | Sidoti |
| 9/5/2023 | $58.00 | Buy → Neutral | Sidoti |
New CBIZ State of Healthcare Report Reveals Cost Increases, Significant Impact of GLP-1 Drugs on Pharmacy Spend, and Regulatory Changes Expanding Employee Protections and Accessibility CBIZ, Inc. (NYSE:CBZ), a leading national professional services advisor, announced the release of its 2025 State of Healthcare Report. The report provides a data-driven look at trends affecting employer-sponsored healthcare and the strategies organizations are using to stay competitive. Now, more than ever, employers face increased pressure to balance affordability with employee wellbeing as healthcare costs continue to rise. The State of Healthcare Report draws on CBIZ's proprietary data from more than 290
CBIZ, Inc. (NYSE:CBZ), a leading national professional services advisor, announced the launch of its CBIZ Tariff Solution, a cross-functional offering designed to help companies address the rising financial, operational, and compliance challenges driven by new and evolving global trade policies. As tariffs reshape global markets and increase pressure on costs, margins, and supply chain stability, middle-market businesses face urgent challenges requiring fast, coordinated responses. The CBIZ Tariff Solution delivers integrated support across finance, tax, operations, and trade strategy, providing the actionable insights businesses need to make informed decisions and protect profitability.
CBIZ, Inc. (NYSE:CBZ), a leading national professional services advisor, announced the appointment of seven new national industry leaders on the heels of announcing six national industry leaders in February. These appointments reinforce CBIZ's commitment to industry specialization and delivering tailored expertise to clients. The newly appointed leaders and their respective industries are: Edward Bechold & David Bukzin – Capital Markets Lou Biscotti – Food & Beverage Tiffany Garcia – Government Jim Low – Financial Services Joseph Natarelli – Construction Beth Wiener – Alternative Investments "The addition of these outstanding leaders further strengthens our ability to deliver
CBIZ, Inc. (NYSE:CBZ), a leading national professional services advisor, announced the appointment of seven new national industry leaders on the heels of announcing six national industry leaders in February. These appointments reinforce CBIZ's commitment to industry specialization and delivering tailored expertise to clients. The newly appointed leaders and their respective industries are: Edward Bechold & David Bukzin – Capital Markets Lou Biscotti – Food & Beverage Tiffany Garcia – Government Jim Low – Financial Services Joseph Natarelli – Construction Beth Wiener – Alternative Investments "The addition of these outstanding leaders further strengthens our ability to deliver
CBIZ, Inc. (NYSE:CBZ), a leading national professional services advisor, today announced the appointment of six new national industry leaders, marking a significant milestone in the ongoing integration of Marcum, which became part of CBIZ in November 2024. These appointments, effective Feb. 1, 2025, reinforce CBIZ's commitment to industry specialization and delivering tailored expertise to clients. The newly appointed leaders and their respective industries are: Michael Brooder – Technology & Life Sciences Doug Fahrnow – Professional Services Seth Goldblum – Private Equity Julie Jones – Not-For-Profit & Higher Education Michael Sacco – Consumer & Industrial Products Abe
CBIZ, Inc. (NYSE: CBZ) ("the Company"), a leading national professional services advisor, today announced the appointment of Kathy Raffa as an independent director to the Company's Board of Directors, effective Jan. 15, 2025. Ms. Raffa was added to the Board of Directors pursuant to CBIZ's acquisition of the non-attest assets of Marcum, which closed Nov. 1, 2024. Ms. Raffa was President of Raffa, PC, a top 100 accounting firm based in Washington, D.C., where she also served as an Audit Partner for over 25 years prior to its merger with Marcum in 2018. She then served as the Office Managing Partner for Marcum's offices in the D.C. region until her retirement in October 2023. Ms. Raffa ha
SC 13G/A - CBIZ, Inc. (0000944148) (Subject)
SC 13G - CBIZ, Inc. (0000944148) (Subject)
SC 13G/A - CBIZ, Inc. (0000944148) (Subject)
FIRST-QUARTER HIGHLIGHTS: TOTAL REVENUE UP 69.5% NET INCOME UP 59.7%; GAAP DILUTED EPS UP 24.8% ADJUSTED EBITDA UP 100.0%; ADJUSTED DILUTED EPS UP 40.5%MARCUM INTEGRATION ON SCHEDULECLEVELAND, April 24, 2025 /PRNewswire/ -- CBIZ, Inc., (NYSE:CBZ) ("CBIZ" or the "Company"), a leading national professional services advisor, today announced results for the first quarter ended March 31, 2025. "CBIZ delivered positive first-quarter results. As we have demonstrated throughout our history, our operating model enables us to deliver strong earnings and cash flow in varying business cli
CLEVELAND, April 16, 2025 /PRNewswire/ -- CBIZ, Inc. (NYSE:CBZ) (the "Company"), a leading national professional services advisor, will announce its financial results for the first quarter ended March 31, 2025, before markets open on Thursday, April 24, 2025. A conference call to discuss the Company's financial results will be hosted by CBIZ President and Chief Executive Officer Jerry Grisko and Chief Financial Officer Brad Lakhia at 11 a.m. (ET) on Wednesday, April 24, 2025. The conference call will be webcast live on the investor relations page of the CBIZ website at https:/
FOURTH-QUARTER HIGHLIGHTS: MARCUM ACQUISITION CLOSED NOVEMBER 1, 2024FOURTH-QUARTER REVENUE UP 40.5%; SAME-UNIT REVENUE UP 6.4%RESULTS INCLUDE MARCUM TRANSACTION AND INTEGRATION EXPENSES AND SEASONAL RESULTS FROM CONSOLIDATED OPERATIONS IN NOVEMBER AND DECEMBERFULL-YEAR HIGHLIGHTS: TOTAL REVENUE UP 14.0%; SAME-UNIT REVENUE UP 4.8%GAAP EPS $0.78; ADJUSTED EPS, EXCLUDING THE IMPACT OF THE MARCUM TRANSACTION AND EXCLUDING ACQUISITION TRANSACTION AND INTEGRATION COSTS, $2.67, UP 10.8%2025 OUTLOOK: TOTAL REVENUE WITHIN A RANGE OF $2.90 BILLION TO $2.95 BILLIONGAAP EPS WITHIN A RANGE OF $1.97 TO $2.02 PER DILUTED SHAREADJUSTED EPS WITHIN A RANGE OF $3.60 TO $3.65 PER DILUTED SHAREADJUSTED EBITDA W
8-K - CBIZ, Inc. (0000944148) (Filer)
10-Q - CBIZ, Inc. (0000944148) (Filer)
8-K - CBIZ, Inc. (0000944148) (Filer)
4 - CBIZ, Inc. (0000944148) (Issuer)
4 - CBIZ, Inc. (0000944148) (Issuer)
4 - CBIZ, Inc. (0000944148) (Issuer)
4 - CBIZ, Inc. (0000944148) (Issuer)
4 - CBIZ, Inc. (0000944148) (Issuer)
Sidoti upgraded CBIZ from Neutral to Buy and set a new price target of $86.00 from $80.00 previously
Sidoti downgraded CBIZ from Buy to Neutral
Sidoti upgraded CBIZ from Neutral to Buy and set a new price target of $63.00